Document Detail


Immune response to ultraviolet-induced tumors. II. Effector cells in tumor immunity.
MedLine Citation:
PMID:  3406977     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Skin tumors induced in mice by chronic ultraviolet irradiation are highly antigenic and can induce a state of transplantation immunity in syngeneic hosts. In the present study, we compared the in vitro cytolytic activity of splenic lymphocytes from mice immunized with either a regressor or a progressor UV-tumor. The results of this comparison supported previous work implicating a role for tumor-specific cytolytic T lymphocytes in the rejection of regressor UV-tumors. The results also revealed that immunization with the progressor UV-tumor 2237 failed to elicit detectable levels of progressor tumor-specific CTL in animals capable of rejecting the immunizing tumor. Interestingly, following in vitro resensitization of both regressor and progressor immune spleen cells, we found a previously undetected lymphocyte population with anti-UV-tumor activity. Besides lysing UV-tumors in vitro, these lymphocytes also lysed a wide variety of additional tumor targets. This effector activity along with the analysis of cell surface markers indicated that these lymphocytes belong to that category of effector cells mediating natural-cell-mediated cytotoxicity (NCMC). As we had not detected cells with this activity in splenic lymphocyte preparations prior to in vitro resensitization, we examined lymphocytes from the local tumor environment during the course of progressor 2237 tumor rejection for either NCMC activity or tumor-specific CTL activity. This in situ analysis revealed lymphocytes exhibiting significant levels of cytolytic activity against several UV-tumors, thus implicating NK cells as effector cells in the rejection of progressor UV-tumors by immune animals. The mechanisms whereby NK cells with NCMC activity could be induced in immune animals are discussed in the context of class-II-restricted immune responses by helper/inducer T lymphocytes.
Authors:
P R Streeter; G W Fortner
Related Documents :
9045907 - Synergy between an antibody and cd8+ cells in eliminating an established tumor.
17195077 - Contribution of the pd-l1/pd-1 pathway to t-cell exhaustion: an update on implications ...
23553917 - Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric ...
10546157 - Immunity to breast cancer in mice immunized with x-irradiated breast cancer cells modif...
20878077 - Pharmacological inhibition of rho-kinase (rock) signaling enhances cisplatin resistance...
19034217 - Liver transplantation in patients with hepatocellular carcinoma.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Transplantation     Volume:  46     ISSN:  0041-1337     ISO Abbreviation:  Transplantation     Publication Date:  1988 Aug 
Date Detail:
Created Date:  1988-09-14     Completed Date:  1988-09-14     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  250-5     Citation Subset:  IM    
Affiliation:
Division of Biology, Kansas State University, Manhattan 66506.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, Differentiation / analysis
Antigens, Neoplasm / analysis
Cytotoxicity, Immunologic
Immunity, Cellular*
Immunity, Innate
Killer Cells, Natural / immunology
Mice
Neoplasm Transplantation
Neoplasms, Radiation-Induced / immunology*
Skin Neoplasms / etiology,  immunology*
Spleen / immunology
Time Factors
Ultraviolet Rays
Grant Support
ID/Acronym/Agency:
CA-09418/CA/NCI NIH HHS; CA-24196/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, Differentiation; 0/Antigens, Neoplasm

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fertility and contraception in the Marshall Islands.
Next Document:  Chronic cyclosporine nephrotoxicity. A rodent model.